Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
The Justice Department also claimed that Abbott purposefully chose not to test for bacterial contamination and that, when the company did perform tests, it did not share positive results with the Food and Drug Administration.
Simplified Text
The Justice Department claimed Abbott purposefully avoided testing for bacterial contamination and did not share positive test results with the FDA.
Confidence Score
1.000
Claim Maker
Justice Department
Context Type
News Article
Context Details
{
    "allegation": "Avoided testing and withheld positive results from FDA",
    "accused_party": "Abbott Laboratories",
    "claiming_body": "Justice Department"
}
Subject Tags
Government Regulation Law
UUID
cc1af8a5-88f7-48c7-907e-06acc2ecd392
Vector Index
✗ No vector
Created
September 18, 2026 at 2:01 AM (3 weeks ago)
Last Updated
September 18, 2026 at 2:01 AM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html
Abbott to Pay $385 Million to Settle Infant Formula Allegations
Completed News
12 claims 🔥
3 weeks ago
https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html

Abbott Laboratories will pay nearly $385 million to settle claims that it knowingly sold infant formula manufactured in facilities that did not meet safety requirements. This follows a 2022 recall linked to serious illnesses in babies and a nationwide formula shortage.

Infant Formula Abbott Laboratories Product Safety Recalls Justice Department Public Health

Similar Claims (5)

Other claims identified as semantically similar to this one.